Atrial natriuretic peptide at discharge as a predictive marker for early rehospitalization in patients with heart failure with preserved ejection fraction

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Junichi Ohno

Hyogo Medical University Kobe campus, Hyogo (Japan)

9 More presentations in this session

Presentation thumbnail

Discussant - Acute heart failure: diagnosis, monitoring, and treatment

Presentation thumbnail

Posture-dependent changes in left atrial pressure: insights from the VECTOR-HF studies

Doctor O. Koren (Tel Aviv, IL)

Presentation thumbnail

Role of mitral regurgitation in a new predictive model for mortality and hospitalization risk in heart failure

Doctor S. Coacci (Sesto San Giovanni, IT)

Presentation thumbnail

Prognostic impact of cardiovascular-kidney-metabolic overlap among patients with acute heart failure: insights from a real-world multinational cohort

Doctor M. Marchetti (Lausanne, CH)

Presentation thumbnail

Prognostic accuracy of natriuretic peptide levels at hospital admission versus discharge for all-cause mortality in patients presenting with acute dyspnea

Doctor D. Wussler (Basel, CH)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Acute heart failure: diagnosis, monitoring, and treatment

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

HFpEF: how to use natriuretic peptides across the heart failure stages

Congress Session

How to use natriuretic peptides in the management of patients with heart failure

Congress Presentation

Evaluating the clinical utility of proBNP in patients with heart failure and low ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources